2018

TitleURLAuthors
 
Rat lung decellularization using chemical detergents for lung tissue engineering.https://www.ncbi.nlm.nih.gov/pubmed/30516069Tebyanian H, Karami A, Motavallian E, Samadikuchaksaraei A, Arjmand B, Nourani MR.
Resveratrol supplementation significantly influences obesity measures: a systematic review and dose-response meta-analysis of randomized controlled trials.https://www.ncbi.nlm.nih.gov/pubmed/30515938Mousavi SM, Milajerdi A, Sheikhi A, Kord-Varkaneh H, Feinle-Bisset C, Larijani B, Esmaillzadeh A.
Oncolytic adenovirus: A tool for cancer therapy in combination with other therapeutic approaches.https://www.ncbi.nlm.nih.gov/pubmed/30515798Goradel NH, Mohajel N, Malekshahi ZV, Jahangiri S, Najafi M, Farhood B, Mortezaee K, Negahdari B, Arashkia A.
MicroRNA in leukemia: Tumor suppressors and oncogenes with prognostic potential.https://www.ncbi.nlm.nih.gov/pubmed/30515779Mardani R, Jafari Najaf Abadi MH, Motieian M, Taghizadeh-Boroujeni S, Bayat A, Farsinezhad A, Gheibi Hayat SM, Motieian M, Pourghadamyari H.
Hybrid poly-l-lactic acid/poly(ε-caprolactone) nanofibrous scaffold can improve biochemical and molecular markers of human induced pluripotent stem cell-derived hepatocyte-like cells.https://www.ncbi.nlm.nih.gov/pubmed/30515778Mobarra N, Soleimani M, Ghayour-Mobarhan M, Safarpour S, Ferns GA, Pakzad R, Pasalar P.
Evaluating the associations between urinary excretion of magnesium and that of other components in calcium stone-forming patients.https://www.ncbi.nlm.nih.gov/pubmed/30515733Tavasoli S, Taheri M, Taheri F, Basiri A, Bagheri Amiri F.
Scalable Architecture for Telemonitoring Chronic Diseases in Order to Support the CDSSs in a Common Platform.https://www.ncbi.nlm.nih.gov/pubmed/30515012Yazdani A, Safdari R, Ghazisaeedi M, Beigy H, Sharifian R.
Developing a Minimum Data Set (MDS) for Cardiac Electronic Implantable Devices Implantation.https://www.ncbi.nlm.nih.gov/pubmed/30515006Kazemi-Arpanahi H, Vasheghani-Farahani A, Baradaran A, Mohammadzadeh N, Ghazisaeedi M.
Epistatic Interaction of ERAP1 and HLA-B*51 in Iranian Patients with Behçet's Disease.https://www.ncbi.nlm.nih.gov/pubmed/30514861Mahmoudi M, Ashraf-Ganjouei A, Javinani A, Shahram F, Meguro A, Mizuki N, Ahmadzadeh N, Jafarinejad-Farsangi S, Mostafaei S, Kavosi H, Faezi ST, Akhlaghi M, Davatchi F.
The risk environments of people who use drugs accessing two harm reduction centers in Tehran, Iran: A qualitative study.https://www.ncbi.nlm.nih.gov/pubmed/30513474Bastani P, Marshall BDL, Rahimi-Movaghar A, Noroozi A.
Showing 231-240 of 3,536 items.